Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-25-004041
Filing Date
2025-01-29
Accepted
2025-01-29 06:39:57
Documents
65

Document Format Files

Seq Description Document Type Size
1 forms-1.htm   iXBRL S-1 3238078
2 ex5-1.htm EX-5.1 15298
3 ex23-1.htm EX-23.1 3869
4 CALCULATION OF FILING FEE TABLE ex107.htm EX-FILING FEES 23384
5 logo_01.jpg GRAPHIC 4839
6 chart_001.jpg GRAPHIC 202522
7 formdrs_001.jpg GRAPHIC 120777
8 logo_001.jpg GRAPHIC 9176
9 ex5-1_001.jpg GRAPHIC 14930
  Complete submission text file 0001493152-25-004041.txt   10369935

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE kapa-20240930.xsd EX-101.SCH 49990
11 XBRL CALCULATION FILE kapa-20240930_cal.xml EX-101.CAL 49360
12 XBRL DEFINITION FILE kapa-20240930_def.xml EX-101.DEF 281217
13 XBRL LABEL FILE kapa-20240930_lab.xml EX-101.LAB 420523
14 XBRL PRESENTATION FILE kapa-20240930_pre.xml EX-101.PRE 344626
67 EXTRACTED XBRL INSTANCE DOCUMENT forms-1_htm.xml XML 1183511
Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Filer) CIK: 0001962011 (see all company filings)

EIN.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-284569 | Film No.: 25566614
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)